SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-026385
Filing Date
2019-10-30
Accepted
2019-10-30 20:05:52
Documents
1
Period of Report
2019-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6761
  Complete submission text file 0000899243-19-026385.txt   9403
Mailing Address 2750 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2750 SAND HILL ROAD MENLO PARK CA 94025 650-233-2750
Kleiner Perkins Caufield & Byers XIV, LLC (Reporting) CIK: 0001505781 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39112 | Film No.: 191181635

Mailing Address 2750 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2750 SAND HILL ROAD MENLO PARK CA 94025 650.233.2750
KPCB XIV Associates, LLC (Reporting) CIK: 0001546196 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39112 | Film No.: 191181636

Mailing Address 2750 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2750 SAND HILL ROAD MENLO PARK CA 94025 650.233.2750
KPCB XIV Founders Fund, LLC (Reporting) CIK: 0001546197 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39112 | Film No.: 191181637

Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Issuer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences